テノホビルおよびエムトリシタビンを含む薬学的製剤

Title:

テノホビルおよびエムトリシタビンを含む薬学的製剤

Document Type and Number:

Japanese Patent JP6978534

Kind Code:

B2

Abstract:

The invention provides a solid oral dosage form comprising tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.

More Like This:

WO/2004/092189	DERIVATIVES OF 2-(8,9-DIOXO-2,6-DIAZABICYCLO(5.2.0)NON-1(7)-EN-2-YL)ALKYL PHOSPHONIC ACID AND THEIR USE AS N-METHYL-D-ASPARTATE (NMDA) RECETOR ANTAGONISTS
JP6695360	(R)-and (S) -1- (3- (3-N, N-dimethylaminocarbonyl) phenoxyl-4-nitrophenyl) -1-ethyl-N, N'-bis (ethylene) phosphorami Date, composition and how to use and manufacture it
JP3404037	Description: Artificial membrane vesicles containing a functionally active fusion peptide as a drug supply system.

Inventors:

Joanna M. Koziara
Scott McAllister

Application Number:

JP2020029330A

Publication Date:

December 08, 2021

Filing Date:

February 25, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Gilead Sciences, Inc.

International Classes:

A61K31/675; A61K9/20; A61K31/513; A61P31/18; A61P43/00

Domestic Patent References:

JP2006516570A
JP2008543861A
JP2015505565A

Attorney, Agent or Firm:

Hidesaku Yamamoto
Natsuki Morishita

Previous Patent: Air battery holder

Next Patent: Impact mitigation device attached to the overhead door and the overhead door equipped with it